The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?

In patients with COVID-19, thromboinflammation is one of the main causes of morbidity and mortality, which makes anticoagulation an integral part of treatment. However, pharmacodynamic and pharmacokinetic properties of direct oral anticoagulants (DOACs) limit the use of this class of anticoagulants...

Descripción completa

Detalles Bibliográficos
Autores principales: Roguljić, Hrvoje, Arambašić, Jerko, Ninčević, Vjera, Kuna, Lucija, Šesto, Igor, Tabll, Ashraf, Smolić, Robert, Včev, Aleksandar, Primorac, Dragan, Wu, George Y., Smolić, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284020/
https://www.ncbi.nlm.nih.gov/pubmed/35722697
http://dx.doi.org/10.3325/cmj.2022.63.287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284020/
https://www.ncbi.nlm.nih.gov/pubmed/35722697
http://dx.doi.org/10.3325/cmj.2022.63.287

Ejemplares similares